Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. | 454,864 | reported | 02 Feb 2026 | tx 53+929,471−593,359 |
| Turnstone Biologics Corp. | 12,770 | reported | 03 Jun 2024 | tx 1+12,770 |
| Epizyme, Inc. | 11,805 | reported | 30 Dec 2015 | tx 64+724,500−1,054,216 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | SALE | Fulcrum Therapeutics, Inc. | 15,000 | 10.72 USD | |
| 02 Jan 2026 | SALE | Fulcrum Therapeutics, Inc. | 15,000 | 11.87 USD | |
| 19 Nov 2025 | SALE | Fulcrum Therapeutics, Inc. | 15,000 | 11.03 USD | |
| 26 Jun 2025 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 36,000 | 0.00 USD | deriv |
| 03 Jun 2024 | GRANT_AWARD | Turnstone Biologics Corp. | 12,770 | 0.00 USD | deriv |
| 17 Jun 2024 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 27 Jun 2023 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 13 Jan 2023 | SALE | Fulcrum Therapeutics, Inc. | 6,766 | 15.00 USD | |
| 27 Jun 2022 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 07 Jun 2022 | SALE | Fulcrum Therapeutics, Inc. | 71,435 | 8.09 USD | |
| 07 Jun 2022 | EXERCISE | Fulcrum Therapeutics, Inc. | 71,435 | 7.84 USD | |
| 07 Jun 2022 | EXERCISE | Fulcrum Therapeutics, Inc. | 71,435 | 0.00 USD | deriv |
| 02 Jun 2022 | SALE | Fulcrum Therapeutics, Inc. | 16,689 | 7.92 USD | |
| 06 Jun 2022 | SALE | Fulcrum Therapeutics, Inc. | 24,382 | 8.10 USD | |
| 03 Jun 2022 | SALE | Fulcrum Therapeutics, Inc. | 25,551 | 7.95 USD | |
| 06 Jun 2022 | EXERCISE | Fulcrum Therapeutics, Inc. | 24,382 | 7.84 USD | |
| 02 Jun 2022 | EXERCISE | Fulcrum Therapeutics, Inc. | 16,689 | 7.84 USD | |
| 03 Jun 2022 | EXERCISE | Fulcrum Therapeutics, Inc. | 25,551 | 7.84 USD | |
| 02 Jun 2022 | EXERCISE | Fulcrum Therapeutics, Inc. | 16,689 | 0.00 USD | deriv |
| 06 Jun 2022 | EXERCISE | Fulcrum Therapeutics, Inc. | 24,382 | 0.00 USD | deriv |
| 03 Jun 2022 | EXERCISE | Fulcrum Therapeutics, Inc. | 25,551 | 0.00 USD | deriv |
| 07 Apr 2022 | SALE | Fulcrum Therapeutics, Inc. | 5,631 | 24.02 USD | |
| 07 Apr 2022 | EXERCISE | Fulcrum Therapeutics, Inc. | 5,631 | 7.84 USD | |
| 07 Apr 2022 | EXERCISE | Fulcrum Therapeutics, Inc. | 5,631 | 0.00 USD | deriv |
| 01 Apr 2022 | EXERCISE | Fulcrum Therapeutics, Inc. | 34,464 | 7.84 USD |